Researchers to implant pig cells in diabetics

A New Zealand biotech company began a trial today of an experimental treatment for diabetes in which cells from newborn pigs will be implanted into eight human volunteers.

Living Cell Technologies hopes the cells may be able to delay the effects of Type 1 diabetes, including blindness, premature coronary illness and limb amputation resulting from poor blood circulation.